Watchlist Price Alert

Oyster Point Pharma Inc. (OYST)

NASDAQ: OYST · Real-Time Price · USD

11.17

0.00 (0.00%)

At close: Dec 30, 2022, 9:00 PM

Oyster Point Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018
Net Income	-176.65M	-157.57M	-129.64M	-100.66M	-80.83M	-79.46M	-72.91M	-70.52M	-68.01M	-63.2M	-58.47M	-45.71M	-30M	-25.13M	-14.4M	-10.64M	-6.63M
Depreciation & Amortization	311K	273K	192K	251K	320K	398K	577K	461K	361K	247K	36K	19K	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	15.42M	14.76M	13.63M	11.95M	11.04M	9.91M	8.47M	6.97M	5.77M	4.84M	4.41M	3.27M	2.32M	1.3M	126K	86K	43K
Other Working Capital	8.85M	11.53M	5.05M	6.72M	-794K	63K	-858K	2.91M	7.39M	5.05M	380K	1.57M	-1.14M	-1.42M	1.16M	1.44M	800K
Other Non-Cash Items	11.54M	10.7M	6.24M	2.12M	5.18M	5.2M	5.07M	5.07M	19K	19K	19K	19K	n/a	n/a	n/a	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	-5.07M	-5.07M	-5.07M	-5.07M	-19K	-19K	-19K	-19K	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-16.6M	-8.98M	-12.96M	-3.03M	410K	-1.36M	-657K	4.69M	8M	6.72M	6.23M	1.61M	-639K	-1.28M	248K	-42K	30K
Operating Cash Flow	-165.98M	-140.82M	-122.55M	-89.37M	-68.95M	-70.39M	-64.52M	-58.4M	-53.88M	-51.4M	-47.8M	-40.81M	-28.32M	-25.12M	-14.03M	-10.6M	-6.56M
Capital Expenditures	-438K	-694K	-1.23M	-1.49M	-1.61M	-1.69M	-1.28M	-1.04M	-772K	-473K	-299K	-200K	-112K	-69K	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	342K	342K	342K	342K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-438K	-694K	-1.23M	-1.49M	-1.61M	-1.69M	-1.28M	-1.04M	-772K	-473K	-299K	-200K	-112K	-69K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	50.99M	91.58M	91.23M	91.64M	40.39M	-205K	112.74M	112.55M	196.38M	195.27M	90.14M	174.99M	91.49M	92.77M	84.85M	n/a	n/a
Financial Cash Flow	50.99M	91.58M	91.23M	91.64M	40.39M	-205K	112.74M	112.55M	196.38M	195.27M	90.14M	174.99M	91.49M	92.77M	84.85M	n/a	n/a
Net Cash Flow	-115.43M	-49.93M	-32.55M	787K	-30.16M	-71.94M	47.28M	53.45M	142.06M	143.4M	42.04M	133.97M	63.06M	67.58M	70.83M	-10.6M	-6.56M
Free Cash Flow	-166.42M	-141.51M	-123.78M	-90.86M	-70.55M	-72.08M	-65.8M	-59.44M	-54.65M	-51.87M	-48.1M	-41.02M	-28.43M	-25.19M	-14.03M	-10.6M	-6.56M